Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FFJ9R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,200
Award facts
- Contract value 100% obligated
- $12,199.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,199.89 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injections on January 2, 2026, with an ultimate completion date of January 5, 2026. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Dupixent is a biologic medication used to treat various inflammatory and immune-mediated conditions, including atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps, making this procurement essential to support federal healthcare requirements.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen Drug Corp supplies a broad portfolio of medications and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive experience fulfilling federal pharmaceutical requirements through competitively awarded contracts demonstrates its capability to meet specialized medical supply demands across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FFJ9R?
SPE2DR26FFJ9R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 2, 2026.
How much is contract SPE2DR26FFJ9R worth?
The government has obligated $12,200 on SPE2DR26FFJ9R.
Is contract SPE2DR26FFJ9R an order under another contract?
Yes. SPE2DR26FFJ9R is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFJ9R competed?
The extent of competition for SPE2DR26FFJ9R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award